Today: 9 July 2026
Browse Category

Earnings Reports 22 June 2026 - 27 June 2026

Intuitive Surgical (NASDAQ:ISRG) holds $400 with analysts split going into Q2

Intuitive Surgical (NASDAQ:ISRG) holds $400 with analysts split going into Q2

Intuitive Surgical Inc. closed out the week higher, but Friday’s close flattered the five-day move. Shares ended Friday up 1.25% at $404.70 on June 26. The weekly advance came in at just 0.43%, according to the company’s LSEG-powered price tool. The stock traded between a low of $398.89 and a high of $412.54 during the week. The range was tight for ISRG, which is still off sharply in 2026.
27 June 2026
··
American Airlines (NASDAQ:AAL) trades above analyst calls, set for earnings pressure as fuel costs ease

American Airlines (NASDAQ:AAL) trades above analyst calls, set for earnings pressure as fuel costs ease

American Airlines Group Inc. traded above where Wall Street analysts had pegged it, before its fuel savings even hit results. Shares ended Thursday at $17.57, up 0.75%, after hitting a 52-week high of $18.04. Analysts’ average target sits at $16.38, with the median at $16.00, according to WSJ. Trading volume surged to 203.4 million shares—about two and a half times the 65-day average of 80.0 million. In pre-market action at 5:01 a.m. EDT, the stock eased 0.4% to $17.50.
26 June 2026
··
JPMorgan CEO search focuses on two divisions behind 85% of Q1 net

JPMorgan CEO search focuses on two divisions behind 85% of Q1 net

JPMorgan Chase & Co. tapped Doug Petno and Troy Rohrbaugh as co-presidents, the Wall Street Journal said, putting both men in the lead to follow Jamie Dimon. In a filing, JPMorgan said Petno, 61, will take over as sole CEO of the Commercial & Investment Bank, while Rohrbaugh, 56, will run Consumer & Community Banking as CEO. Marianne Lake is retiring after over 25 years at the company.
25 June 2026
·
McCormick (NYSE:MKC) gains after Q2 results, some gains tied to tariff refund and Mexico deal

McCormick (NYSE:MKC) gains after Q2 results, some gains tied to tariff refund and Mexico deal

McCormick & Company, Incorporated looked ready for gains in Thursday’s premarket after topping estimates last quarter, but a big chunk of the beat came from a tariff refund, leaving the picture less clear. Thursday was a regular trading day on NYSE’s 2026 schedule; at 08:05 EDT, trading hadn’t started yet. The main session would open at 9:30 a.m. and close at 4:00 p.m. Eastern.
25 June 2026
···
Nasdaq edges lower in after-hours as AI chip fall spurs margin chatter

US stocks open higher with Micron earnings in focus, traders eye Fed

Stocks pushed higher in the U.S. on Wednesday, with the S&P 500 up 0.44%, the Nasdaq gaining 0.39%, and the Dow rising 0.53% in late-morning trading, Reuters reported, citing market data delayed at least 15 minutes. Consumer discretionary and healthcare names were strong, but energy slipped after oil prices moved lower.
24 June 2026
········
Micron Shares Reach All-Time High with AI Memory Demand in Focus Ahead of Earnings

Micron stock steadies ahead of earnings as AI memory run faces pressure

Micron Technology shares slipped early Wednesday as investors looked ahead to the memory-chip company’s fiscal Q3 earnings, a release many see as a gauge for the AI trade after recent pressure on chip names. Micron was down 0.33% at $1,048.34 as of 9:56 a.m. EDT, trading between $1,032 and $1,083.32 so far, according to MarketWatch.
24 June 2026
····
1 2 3 4 5 6 … 261

Stock Market Today

  • COMPASS Pathways (CMPS) Jumps 296%, Trades at Steep Premium as Investors Weigh Outlook
    July 8, 2026, 11:08 PM EDT. Shares of COMPASS Pathways (CMPS) have run up almost 296% in the last year after positive Phase 3 results on its COMP360 therapy for treatment-resistant depression. But the stock's price-to-book stands at 5.8x, well above the industry's 2.8x average, putting it at a hefty premium. Still pre-revenue, COMPASS isn't trading on traditional earnings measures. Uncertainty around regulatory decisions and commercial adoption keeps sentiment cautious. Simply Wall St gives COMPASS a 3 out of 6 for valuation, flagging mixed views. The decision for investors is whether future growth prospects justify the current price or if valuation risks are too high.
Go toTop